multivessel

FUTURE: aumento de la mortalidad en la rama FFR

FUTURE: Mortality Increase in the FFR Arm, Real or Casual?

The FUTURE study, testing the&nbsp;utility of functional revascularization by measuring the fractional flow reserve (FFR), was halted early by its safety committee due to an increased mortality rate at 1&nbsp;year among patients guided by FFR. &nbsp; In this unexpected unprecedented outcome, 17&nbsp;patients in the FFR-guided group died at a year of follow-up, compared with 7&nbsp;patients<a href="https://solaci.org/en/2016/12/01/future-mortality-increase-in-the-ffr-arm-real-or-casual/" title="Read more" >...</a>

scai_solaci jornadas chile

SCAI-SOLACI Symposium at Chile Sessions on Complex Caradiomyopathy

The symposium will take place on December 1, 2016, from 10:15 to 11:30, at &#8220;Osorno A&#8221; Room of Patagónico Hotel in Puerto Varas, in the context of SOLACI Sessions Chile 2016. &nbsp; This event on complex cardiomyopathy is organized by the Society for Cardiovascular Angiography and Interventions (SCAI) together with SOLACI. &nbsp; Moderators are Drs.<a href="https://solaci.org/en/2016/11/23/scai-solaci-symposium-at-chile-sessions-on-complex-caradiomyopathy/" title="Read more" >...</a>

Discover which were the best e-posters

FIRST PLACE 114 THE IMPACT OF POST-PROCEDURAL ASYMMETRY, EXPANSION AND ECCENTRICITY OF BIORESORBABLE EVEROLIMUS-ELUTING SCAFFOLD AND METALLIC EVEROLIMUS-ELUTING STENT ON CLINICAL OUTCOMES IN THE ABSORB II TRIAL PANNIPA SUWANNASOM1; YOHEI SOTOMI1; RAFAEL CAVALCANTE E SILVA2; CARLOS MACAYA3; JOHN A ORMINSTON4; JONATHAN HILL5; MACIEJ LESIAK6; BERNARD CHEVALIER7; PATRICK W SERRUYS8; YOSHINOBU ONUMA2 1.ACADEMIC MEDICAL CENTER, HOLLAND;<a href="https://solaci.org/en/2016/07/01/discover-which-were-the-best-e-posters/" title="Read more" >...</a>

reserva fraccional de flujo

Post PCI FFR Reduces MACE

Original Title: Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes Reference: Shiv K. Agarwal, et al. JACC Cardiovascular Intervention 2016;9:1022-31 &nbsp; Courtesy of Dr. Carlos Fava. &nbsp; Fractional flow reserve has shown benefits and it is considered the gold standard to assess intermediate lesions (Class IA), but its<a href="https://solaci.org/en/2016/06/29/post-pci-ffr-reduces-mace/" title="Read more" >...</a>

cobertura congreso

June 8, 2016

Rio de Janeiro – June 8, 2016. &nbsp; SOLACI-SBHCI 2016, the largest meeting on Interventional Cardiology in Latin America started with more than 1500 attendees. After the opening, by Congress President Marcelo Josén de Carvalho Cantarelli, we honored Dr. José Eduardo Sousa, the first to perform a coronary catheterization in Brazil, 50 years ago. After<a href="https://solaci.org/en/2016/06/15/june-8-2016/" title="Read more" >...</a>

P.W.Serruys

SYNTAX II: Initial outcomes of FFR/iFR and IVUS guided PCI with last generation DES in 3 vessel patients

Original Title: iFR/FFR and IVUS-guided percutaneous coronary revascularization with new-generation DES in patients with de novo three-vessel disease: 30-day outcomes of the SYNTAX II trial. Presenter: P. W. Serruys. &nbsp; The European Society of Cardiology guidelines recommend PCI for patients with multivessel disease and a Syntax score. A prospective, multicenter, single arm study was carried<a href="https://solaci.org/en/2016/05/23/syntax-ii-initial-outcomes-of-ffr-ifr-and-ivus-guided-pci-with-last-generation-des-in-3-vessel-patients/" title="Read more" >...</a>

stent-liberador-drogas-sirolimus-everolimus

LV: Everolimus Eluting Stents vs. Coronary Artery Bypass Graft

Original Title: Revascularization in Patients with Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus Eluting Stents vs Coronary Artery Bypass Graft Surgery Reference: Bangalore et al. Circulation. 2016 May 5. Epub ahead of print. &nbsp; Courtesy of Dr. Guillermo Migliaro. &nbsp; Guidelines recommend coronary artery bypass graft surgery (CABG) over percutaneous coronary<a href="https://solaci.org/en/2016/05/16/lv-everolimus-eluting-stents-vs-coronary-artery-bypass-graft/" title="Read more" >...</a>

Is normal FFR always good prognosis?

Original Title: Coronary Flow Reserve and Microcirculatory Resistance in Patients with Intermediate Coronary Stenosis. Reference: Joo Myung Lee, el al. J Am Coll Cardiol 2016; 67:1158-69 Courtesy of Dr. Carlos Fava. Measuring fractional flow reserve (FFR) helps establish whether intermediate stenosis will generate ischemia, but it won’t help assess microcirculatory function. It has been shown that<a href="https://solaci.org/en/2016/03/16/is-normal-ffr-always-good-prognosis/" title="Read more" >...</a>

Successful recanalization of total occlusion: No improvement of long-term survival

Original Title: Successful Recanalization of Native Coronary Chronic Total Occlusion Is Not Associated With Improved Long-Term Survival. Reference: Pil Hyung Lee et al. J Am Coll Cardiol Intv. 2016. Online before print. &nbsp; The aim of this study was to assess long term clinical outcomes after successful recanalization of chronic total occlusion (CTO) with DES<a href="https://solaci.org/en/2016/03/03/successful-recanalization-of-total-occlusion-no-improvement-of-long-term-survival/" title="Read more" >...</a>

Diabetes has higher impact on DES outcomes than disease complexity

Original Title: Impact of diabetic status on outcomes after revascularization with drug-eluting stents in relation to coronary artery disease complexity. Reference: Koskinas KC et al. Circ Cardiovasc Intv. 2016; Epub ahead of print &nbsp; Diabetic patients ongoing PCI with drug eluting stents (DES) are at higher risk of repeat revascularization than non-diabetic patients. According to this<a href="https://solaci.org/en/2016/02/22/diabetes-has-higher-impact-on-des-outcomes-than-disease-complexity/" title="Read more" >...</a>

Top